1/53
Looks like no tags are added yet.
first step of neurotransmitter action
neurotransmitter molecules are synthesized from precursors under the influence of enzymes
second step of neurotransmitter action
neurotransmitter molecules are stored in vesicles until their release into the synaptic cleft after an action potential arrives
third step of neurotransmitter action
neurotransmitter molecules that leak from their vesicles are destroyed by enzymes
fourth step of neurotransmitter action
action potentials cause vesicles to fuse with the presynaptic membrane and release their neurotransmitter molecules into the synapse
fifth step of neurotransmitter action
released neurotransmitter molecules bind with autofirst step of neurotransmitter action receptors and inhibit subsequent neurotransmitter release
sixth step of neurotransmitter action
released neurotransmitter molecules bind to postsynaptic receptors
seventh step of neurotransmitter action
released neurotransmitter molecules are deactivated by either reuptake or enzymatic dgonaegradation
agonistic drug effects
drug increases the synthesis of neurotransmitter molecules, increases the number of neurotransmitter molecules by destroying degrading enzymes, increases the release of neurotransmitter molecules from terminal buttons. binds to auto receptors and blocks inhibitory effect on neurotransmitter release, and ends to postsynaptic receptors and either activates them or increases the effect on them of neurotransmitter
antagonist drug effect
drug blocks synthesis of neurotransmitter molecules, causes neurotransmitter molecules to leak from vesicles and be destroyed by degrading enzymes, blocks the release of the neurotransmitter molecules from terminal buttons, activates auto receptors and inhibits neurotransmitter release, and is a receptor blocker; binds to postsynaptic receptors and blocks the effect of the neurotransmitter
drugs can function…
as agonists or antagonists at receptors
receptors
membrane proteins bound to and activated by neurotransmitters
autoreceptor
presynaptic receptor activated by neurotransmitters that are released from same axon terminal
drugs that are antagonists at receptors have
an agonistic effect with respect to synaptic communication
heteroreceptor
presynaptic receptor activated by neurotransmitters that are different from those released from axon terminal
presynaptic inhibition
opening of calcium channels is inhibitedat the presynaptic terminal, reducing neurotransmitter release.
presynaptic facilitation
opening of calcium channels is facilitated
calcium channels
must open to permit release of neurotransmitter
based on ____, receptors can be classified into two broad categories
structural and functional characteristics
categories of receptors
ionotropic receptors and metabotropic receptors
inotropic receptors
are comprised of multiple protein subunits which form an ion channel pore
metabotropic receptors
are individual (large) proteins (that traverse membrane multiple times) and are indirectly linked with ion channels on the plasma membrane of the cell through signal transduction mechanisms, often G proteins
differences ionotropic vs metabotropic receptors
inotropic are fast on/off, all or none on/off, triggers action potentials, made up of multiple interchangeable subunits — metabotropic are slower off/off, can amplify or dampen signals, triggers multiple post-synaptic events, including action potentials, monomers
Gs pathway
is a signaling pathway that stimulates adenylate cyclase, increasing the production of cyclic AMP (cAMP) and activating protein kinase A (PKA), which leads to various cellular responses.
second messengers are
small intracellular molecules that transmit and amplify signals inside a cell after a receptor is activated
first messenger
an extracellular signal binds to receptor on the cell membrane
example of second messenger
ion channel opening, enzyme activity, or gene expression
main steps in gene expression
transcription - DNA is copied into messenger RNA
translation - mRNA used as a template by ribosome to build a protein
CREB
(cAMP response element-binding protein) - a cellular transcription factor, it binds to certain DNA sequences called cAMP response elements (CRE), thereby increasing or decreasing the transcription of the genes
genes whose transcription are regulated by CREB include
c-fos
c-fos
a transcription factor that can promote the expression of AMPA receptor subunits
effector protein in Gs pathway
adenylate cyclasee
effector protein in Gq pathway
phospholipase C
effector protein in Gi pathway
adenylate cyclase inhibition
second messengers in Gs pathway
cAMP
second messengers in Gq pathway
DAG and IP3
second messengers in Gi pathway
cAMP reduction
later effectors in Gs pathway
protein kinase A
later effectors in Gq pathway
protein kinase C from DAG and calcium release from IP3
what doe the Gs pathway do
increase protein phosphorylation
what does Gq pathway do
increase protein phosphorylation and activate Ca2+-binding proteins
what does Gi pathway do
decrease protein phosphorylation
physical proximity to parts of neuron where effects exerted (ionotropic receptor and metabotropic receptor)
ionotropic receptor- attached to ion channel; metabotropic receptor - separated from ion channels and other proteins
type of effect differences
ionotropic receptor - open ion channel, metabotropic receptor - uses G protein to activate ion channels and effector enzymes
duration of effect differences
ionotropic receptor - ends when neurotransmitter leaves binding site; metabotropic receptor - effector enzymes engage a cascade of events that persist after neurotransmitter leaves receptor
impact on a neuron differences
ionotropic receptor -influx of ions changes local potential; metabotropic receptor - can affect local potentials and other effects like enzyme regulation, gene expression and protein synthesis
what defines a neurotransmitter
synthesis
release
receptor action
inactivation
neurotransmitter synthesis
some neurotransmitters are transported from the cell nucleus to the terminal button , others made from building blocks imported into the terminal, are packaged into vesicles there
neurotransmitter release
in response to an action potential, the transmitter is released across the membrane by exocytosis
neurotransmitter receptor action
the transmitter crosses the synaptic cleft and binds to a receptor
neurotransmitter inactivation
the transmitter is either taken back into the terminal or inactivated in the synaptic cleft
neurotransmitter categories
amino acids, modified amino acids, monoamines, neuropeptides, gases
monoamines - neurotransmitters
indoleamines(serotonin) and catecholamines (dopamine, norepinephrine, epinephrine)
types of amino acid neurotransmitters
glutamate and gaba